Satoh Hironori, Tazawa Ryushi, Sakakibara Tomohiro, Ohkouchi Shinya, Ebina Masahito, Miki Makoto, Nakata Koh, Nukiwa Toshihiro
Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Japan.
Intern Med. 2012;51(13):1737-42. doi: 10.2169/internalmedicine.51.6093. Epub 2012 Jul 1.
A 55-year-old non-smoking woman was admitted to our hospital for re-evaluation of unimproved peripheral ground-glass opacities despite prednisolone and cyclosporine treatment. She was diagnosed with autoimmune pulmonary alveolar proteinosis (PAP) based on transbronchial lung biopsy and granulocyte/macrophage colony-stimulating factor (GM-CSF) antibody testing. GM-CSF inhalation therapy markedly improved the opacities. Bilateral, centrally located lung opacities are typical in PAP, however 10 PAP cases with peripheral infiltration were reported in Japan recently, of which GM-CSF antibody was positive in six. To avoid inappropriate immunosuppressant treatment, PAP should be considered in the differential diagnosis of such peripheral opacities. GM-CSF antibody might be useful for diagnosis.
一名55岁的不吸烟女性因尽管接受了泼尼松龙和环孢素治疗但外周磨玻璃影仍未改善而入院接受重新评估。根据经支气管肺活检和粒细胞/巨噬细胞集落刺激因子(GM-CSF)抗体检测,她被诊断为自身免疫性肺泡蛋白沉积症(PAP)。GM-CSF吸入疗法显著改善了肺部阴影。双侧中央型肺部阴影是PAP的典型表现,然而最近在日本报道了10例伴有外周浸润的PAP病例,其中6例GM-CSF抗体呈阳性。为避免不适当的免疫抑制治疗,在鉴别诊断此类外周阴影时应考虑PAP。GM-CSF抗体可能有助于诊断。